Akshar Spintex Stock at ₹0.52: Bargain or Trap in 2025?
Trading at just ₹0.52 as of December 23, 2025, Akshar Spintex (AKSHAR) looks like a penny stock steal—debt-free and below book value. But recent numbers paint a tougher picture, with falling sales and losses piling up. Here’s the real story in simple terms, so you can decide if it’s worth watching.
Latest Price & Quick Stats
Akshar Spintex closed around ₹0.52-₹0.53 recently, down 30% in the past year and 5% in six months. Market cap sits at about ₹48 crore, with a 52-week range of ₹0.49-₹0.79. It’s a micro-cap textile player, meaning big swings but low visibility.
Why It’s Struggling Now
Revenue dropped to ₹22.81 crore in Sep 2025 (from ₹31.44 crore in Mar), with net losses hitting ₹1.97 crore quarterly. Profits have tanked 737% yearly, ROE is negative, and sales growth over five years? Just 1.36%. Promoter holding is tiny at 0.27%, signaling low insider confidence.
A Few Silver Linings
No debt is a win—no interest eating profits. It trades below book value, so theoretically undervalued. Recent regulatory nods could help operations, per SFAC updates. Technicals show mild bullish hints short-term, despite the gloom.
Smart Next Steps
Skip the hype from old 2023 videos promising 80% upside—2025 reality is riskier. Check Q3 results yourself on NSE or Screener.in, watch for sales turnaround or promoter buys. Great for high-risk traders, but most folks? Proceed with caution—it’s no quick riches play.
Key Financial Ratios Reveal Akshar Spintex’s Weak Health in 2025
Akshar Spintex (AKSHAR), trading at ₹0.62 as of late December 2025, shows poor financial vitality through core profitability and efficiency ratios. These metrics highlight ongoing losses and operational strain, making it a high-risk micro-cap. Focus on ROE, ROCE, and working capital for the clearest picture.
Profitability Red Flags
Return on Equity (ROE) stands at -6.72% currently, with a 3-year average of -2.49%—meaning shareholders’ investments lose value yearly. ROCE is -6.01%, down sharply from past highs like 19% in 2022, as losses eat into capital efficiency. Operating Profit Margin (OPM) hit -5% TTM, reflecting sales unable to cover costs amid declining revenue.
Efficiency & Liquidity Issues
Working Capital Days ballooned to 154 from 67 a few years back, tying up cash in slow inventory (155 days) and receivables. Cash Conversion Cycle stretched to 171 days, signaling poor turnover—company generates just ₹106 Cr TTM sales against ₹98 Cr assets. Low interest coverage adds borrowing pressure despite near debt-free status.
Valuation Context
P/B ratio at 0.54x looks cheap versus book value of ₹1.12, but negative earnings (TTM EPS -₹0.08) render PE meaningless. Promoter holding at 0.27% stays alarmingly low, eroding confidence. These ratios collectively warn of stagnation over growth.
This Akshar Spintex analysis draws from public financial data as of December 2025.(see the generated image above) Key sources include Screener.in for ratios like ROE (-6.72%) and Moneycontrol for price trends (₹0.52-₹0.62).
Important Notes
Information reflects the latest available reports—markets change fast; verify real-time data on NSE/BSE. Not financial advice; consult a certified advisor before investing. Past performance doesn’t guarantee future results.
